CTI Vascular AG
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Apr 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 27, 2027The maintenance fee for Apparatus for treating a patient having a heart (US 10,391,297) comes due Feb 27, 2027. Unpaid by Aug 27, 2027, it lapses early.
- 1 fee due Jul 9, 2027The maintenance fee for Precutaneous-transluminal methods that minimize vessel stress and trauma (US 11,865,279) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
- 1 fee due Sep 26, 2027The maintenance fee for Usable-length-selectable catheter to treat vascular pathologies (US 11,938,286) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
- 1 fee due Oct 28, 2027The maintenance fee for Catheter system for treating vascular and non-vascular diseases (US 10,632,005) comes due Oct 28, 2027. Unpaid by Apr 28, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,391,297 | Apparatus for treating a patient having a heart In force · From the USPTO record | In force | From the USPTO record | |
| US 10,688,276 | Length-adjustable catheter and method that employs a length-adjustable catheter to treat vascular pathologies In force · From the USPTO record | In force | From the USPTO record | |
| US 10,632,005 | Catheter system for treating vascular and non-vascular diseases In force · From the USPTO record | In force | From the USPTO record | |
| US 11,938,286 | Usable-length-selectable catheter to treat vascular pathologies In force · From the USPTO record | In force | From the USPTO record | |
| US 12,458,599 | Bioactivatable Devices and Related Methods In force · High confidence | In force | High confidence | |
| US 12,214,147 | Angioplasty balloon catheter for treating vascular disease In force · From the USPTO record | In force | From the USPTO record | |
| US 11,865,279 | Precutaneous-transluminal methods that minimize vessel stress and trauma In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 7: 3 patents in force now held by others · 1 lapsed for an unpaid fee · 1 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 no status recorded